Form 4: Catalyst Pharmaceuticals Director Patrick McEnany Donates 45,000 Shares to Charity

Patrick McEnany, a Director at Catalyst Pharmaceuticals, gifted 45,000 shares of common stock to the Baptist Health South Florida Foundation on August 15, 2024.

Summary

• On August 15, 2024, Patrick J. McEnany, a Director and Chairman of the Board at Catalyst Pharmaceuticals, donated 45,000 shares of the company's common stock to the Baptist Health South Florida Foundation.
• The transaction was a charitable gift, and Mr. McEnany received no compensation for the shares.
• Following the transaction, Mr. McEnany beneficially owns 4,483,269 shares of Catalyst Pharmaceuticals.
• The reporting person retains no control over the shares gifted.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a charitable donation, which doesn't necessarily reflect positively or negatively on the company's performance. The insider is reducing their holdings, but it's for a good cause and doesn't suggest a lack of confidence in the company.

Industry Context

Insider transactions, such as charitable donations, are routinely disclosed and monitored by investors for insights into management's perspective on the company's value and prospects. However, a charitable donation is less indicative than a sale or purchase.

Stakeholder Impact

• The donation may have a minor positive impact on the Baptist Health South Florida Foundation.
• The impact on shareholders is likely negligible.

Key Dates